These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15447073)

  • 1. Case report: anti-Cra in pregnancy.
    Dickson AC; Guest C; Jordon M; Banks J; Kumpel BM
    Immunohematology; 1995; 11(1):14-7. PubMed ID: 15447073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequestration of anti-Cra in the placenta: serologic demonstration by placental elution.
    Weber SL; Bryant BJ; Indrikovs AJ
    Transfusion; 2005 Aug; 45(8):1327-30. PubMed ID: 16078921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate hemolytic disease of the newborn due to anti-Hr0 in a mother with the D--/D-- phenotype.
    Lenkiewicz B; Zupanska B
    Immunohematology; 2000; 16(3):109-11. PubMed ID: 15373614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do monocyte ADCC assays accurately predict the severity of hemolytic disease of the newborn caused by antibodies to high-frequency antigens?
    Garner SF; Devenish A
    Immunohematology; 1996; 12(1):20-6. PubMed ID: 15387757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemolytic disease of the newborn caused by maternal anti-Di(a): a case report in Taiwan].
    Yung CH; Lin JS; Hu HY; Lyou JY; Chen YR; Chen CR; Hao TC; Peng CS; Tzeng CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1995 May; 28(2):146-50. PubMed ID: 9774993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent anti-Dra in two pregnancies.
    Rahimi-Levene N; Kornberg A; Siegel G; Morozov V; Shinar E; Asher O; Levene C; Yahalom V
    Immunohematology; 2005; 21(3):126-8. PubMed ID: 16178671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Jk3 with no clinical evidence of HDN.
    Hunter CJ; Ziebol MD
    Immunohematology; 1997; 13(4):136-7. PubMed ID: 15387767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate hemolytic disease of the newborn (HDN) due to anti-Rh17 produced by a black female with an e variant phenotype.
    Brumit MC; Carnahan GE; Stubbs JR; Storry JR; Reid ME
    Immunohematology; 2002; 18(2):40-2. PubMed ID: 15373563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of red cells preserved in extended storage media for exchange transfusion in anti-k haemolytic disease of the newborn.
    Win N; Amess P; Needs M; Hewitt PE
    Transfus Med; 2005 Apr; 15(2):157-60. PubMed ID: 15859984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [High-throughput genotyping multiplex ligation-dependent probe amplification for assisting diagnosis in a case of anti-Di(a)-induced severe hemolytic disease of the newborn].
    Ji Y; Mo C; Wei L; Zhou X; Zhang R; Zhao Y; Luo H; Wang Z; Luo G
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):234-8. PubMed ID: 22381766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-M Antibody Induced Prolonged Anemia Following Hemolytic Disease of the Newborn Due to Erythropoietic Suppression in 2 Siblings.
    Ishida A; Ohto H; Yasuda H; Negishi Y; Tsuiki H; Arakawa T; Yagi Y; Uchimura D; Miyazaki T; Ohashi W; Takamoto S
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e375-7. PubMed ID: 25929611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient.
    Leatherbarrow MB; Ellisor SS; Collins PA; Douglas DK; Eckrich RJ; Esty SS; Baldwin ML; Ness PM
    Immunohematology; 1988; 4(4):71-4. PubMed ID: 15945939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic and molecular genetic management of a pregnancy complicated by anti-Rh18.
    Haspel RL; Vege S; Michelle D; Kaufman RM; Westhoff CM
    Immunohematology; 2006; 22(3):132-5. PubMed ID: 17105362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Holley detected in a primary immune response.
    Barrett VJ; O'Brien MM; Moulds JJ; Spruell P; Jackson V; Stubbs JR
    Immunohematology; 1996; 12(2):62-5. PubMed ID: 15387742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Mta associated with three cases of hemolytic disease of the newborn.
    Cheung CC; Challis D; Fisher G; Russell SJ; Davis A; Bruce H; Watt J; Chong BH
    Immunohematology; 2002; 18(2):37-9. PubMed ID: 15373562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the enzyme test for the detection of clinically significant red blood cell antibodies during pregnancy.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Acta Med Croatica; 1999; 53(3):125-8. PubMed ID: 10705633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family showing inheritance of the Inab phenotype.
    Lin RC; Herman J; Henry L; Daniels GL
    Transfusion; 1988; 28(5):427-9. PubMed ID: 3420669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal alloanti-hrS--an absence of HDN.
    Kakaiya R; Cseri J; Jochum B; Gillard L; Silberman S
    Immunohematology; 2004; 20(3):187-9. PubMed ID: 15373651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically significant hemolytic disease of the newborn secondary to passive transfer of anti-D from maternal RhIG.
    Cohen DN; Johnson MS; Liang WH; McDaniel HL; Young PP
    Transfusion; 2014 Nov; 54(11):2863-6. PubMed ID: 24826985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.